Abstract
Attempting to improve the anticancer activity and solubility of evodiamine in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) solutions, thirty-eight N13-substituted evodiamine derivatives were designed, synthesized and tested for antitumor activities against six kinds of human cancer cell lines, namely prostate cancer (DU-145 and PC-3), lung cancer (H460), breast cancer (MCF-7), colon cancer (HCT-5) and glioblastoma (SF-268). The solubility of these compounds in SGF and SIF solutions was evaluated, and apoptosis induced by 2-2, 2-3, 2-16 and 3-2 was determined. The results showed: (1) among all compounds examined, 2-16 showed the highest antitumor activity and a broader spectrum of activity, with IC50 values ranging from 1-2 µM; (2) their solubility was obviously improved; (3) 2-3, 2-16 and 3-2 had a significant impact inducing apoptosis in some cancer cell lines. The preliminary structure-activity relationships of these derivatives were discussed.
References
Feb 12, 2005·Carcinogenesis·Cho-Hwa LiaoChe-Ming Teng
Nov 11, 2005·Life Sciences·Kou-Gi ShyuShiow-Chwen Tsai
Mar 7, 2007·Journal of Cellular Biochemistry·Shu-Fen KanPaulus S Wang
Apr 23, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Agnes L-F ChanJau-Lang Hwang
May 28, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Junlin Jiang, Changping Hu
Jun 25, 2009·Chemistry & Biodiversity·Zhi-Gang YangBo Liu
Oct 27, 2009·FEBS Letters·Ting WangHitoshi Yamashita
Dec 17, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Che WangMin-wei Wang
May 27, 2010·Journal of Cellular Biochemistry·Meng-Ching ChenPaulus S Wang
Jun 5, 2010·Indian Journal of Pharmacology·Susanta Kumar MondalUpal Kanti Mazumder
Jul 16, 2010·Bioorganic & Medicinal Chemistry Letters·Zhiyong ChenWenlie Peng
Jul 22, 2010·Anti-cancer Drugs·Chun ZhangHua-Ping Liang
Aug 6, 2010·Cancer Letters·Min Li-Weber
Sep 18, 2010·European Journal of Medicinal Chemistry·Chunming MaHuacan Song
Oct 15, 2010·Journal of Medicinal Chemistry·Guoqiang DongWannian Zhang
May 17, 2011·Bioorganic & Medicinal Chemistry Letters·Yanmin HuangHuacan Song
Aug 31, 2011·European Journal of Medicinal Chemistry·Zhiyong ChenHuacan Song
Jan 3, 2012·International Journal of Biological Sciences·Wei-Tian WeiSheng-Zhang Lin
Mar 1, 2012·Oncology Reports·Azhar RasulTonghui Ma
Mar 10, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xiaobei PanS W Annie Bligh
Aug 8, 2012·Journal of Medicinal Chemistry·Guoqiang DongChunquan Sheng
Sep 4, 2012·International Journal of Molecular Sciences·Zhanli WangHuaping Liang
Oct 4, 2012·Cancer Letters·Jie YangPeng Cao
Jan 3, 2013·European Journal of Medicinal Chemistry·Buxi ShiHuacan Song
Feb 26, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui YuHuaping Liang
Jun 28, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yanmin HuangAimin Zhou
Jul 11, 2013·PloS One·Kai-Lee WangShyi-Wu Wang
Citations
Aug 1, 2015·Journal of Medicinal Chemistry·Shengzheng WangChunquan Sheng
Dec 17, 2014·PloS One·Chunshu FangQunyou Tan
Dec 17, 2017·The Journal of Pharmacology and Experimental Therapeutics·Jamie R FriedmanPiyali Dasgupta
Oct 2, 2019·Organic & Biomolecular Chemistry·Yiting SuHaijun Chen
Apr 2, 2019·Current Topics in Medicinal Chemistry·Benjamin Diethelm-VarelaFengtian Xue
Nov 2, 2018·International Journal of Molecular Sciences·Xu HuFanxing Xu